SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-000034
Filing Date
2021-01-04
Accepted
2021-01-04 16:05:14
Documents
1
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-50806.html 4  
1 PRIMARY DOCUMENT marketforms-50806.xml 4 9614
  Complete submission text file 0001214659-21-000034.txt   11018
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Kendall Keith J (Reporting) CIK: 0001406834 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 21501801